The Role of TWIST in Ovarian Epithelial Cancers
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Epithelial-mesenchymal transition (EMT) is associated with tumor hypoxia. EMT is regulated, in part, by the action of TWIST, which inhibits of E-cadherin expression and may interfere with the p53 tumor-suppressor pathway. Methods: We examined the expression of TWIST, E-cadherin, hypoxia-inducible factor 1α (HIF1α), and p53 by immunohistochemistry in 123 cases of ovarian epithelial cancers (OEC) to evaluate the role of TWIST in OEC. We assessed the association between protein expression and clinicopathologic parameters. Results: The expression of TWIST, E-cadherin, HIF1α, and p53 proteins was found in 28.5%, 51.2%, 35.0%, and 29.3% of cases, respectively. TWIST expression was associated with higher histologic grade and unfavorable survival. TWIST expression was correlated with HIF1α expression and reduced E-cadherin expression. The altered HIF1α/TWIST/E-cadherin pathway was associated with lower overall survival(OS), while the co-expression of TWIST and p53 was correlated with lower progression-free survival. In the multivariate analyses, TWIST expression was an independent prognostic factor for OS. Conclusions: Our data imply that TWIST expression could be a useful predictor of unfavorable prognosis for OEC. TWIST may affect the p53 tumor-suppressor pathway. Moreover, hypoxia-mediated EMT, which involves the HIF1α/TWIST/E-cadherin pathway may play an important role in the progression of OEC.
Abstract
Background: Epithelial-mesenchymal transition (EMT) is associated with tumor hypoxia. EMT is regulated, in part, by the action of TWIST, which inhibits of E-cadherin expression and may interfere with the p53 tumor-suppressor pathway. Methods: We examined the expression of TWIST, E-cadherin, hypoxia-inducible factor 1α (HIF1α), and p53 by immunohistochemistry in 123 cases of ovarian epithelial cancers (OEC) to evaluate the role of TWIST in OEC. We assessed the association between protein expression and clinicopathologic parameters. Results: The expression of TWIST, E-cadherin, HIF1α, and p53 proteins was found in 28.5%, 51.2%, 35.0%, and 29.3% of cases, respectively. TWIST expression was associated with higher histologic grade and unfavorable survival. TWIST expression was correlated with HIF1α expression and reduced E-cadherin expression. The altered HIF1α/TWIST/E-cadherin pathway was associated with lower overall survival(OS), while the co-expression of TWIST and p53 was correlated with lower progression-free survival. In the multivariate analyses, TWIST expression was an independent prognostic factor for OS. Conclusions: Our data imply that TWIST expression could be a useful predictor of unfavorable prognosis for OEC. TWIST may affect the p53 tumor-suppressor pathway. Moreover, hypoxia-mediated EMT, which involves the HIF1α/TWIST/E-cadherin pathway may play an important role in the progression of OEC.
참고문헌 (27)
- Siegel R, "Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths", CA Cancer J Clin, 61, pp.212~236 (2011)
- Naora H, "Ovarian cancer metastasis: integrating insights from disparate model organisms", Nat Rev Cancer, 5, pp.355~366 (2005)
- Friedlander ML, "Prognostic factors in ovarian cancer", Semin Oncol, 25, pp.305~314 (1998)
- Thiery JP, "Complex networks orchestrate epithelial-mesenchymal transitions", Nat Rev Mol Cell Biol, 7, pp.131~142 (2006)
- Yang J, "Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis", Cell, 117, pp.927~939 (2004)
- Puisieux A, "A twist for survival and cancer progression", Br J Cancer, 94, pp.13~17 (2006)
- Markiewicz A, "Expression of epithelial to mesenchymal transition-related markers in lymph node metastases as a surrogate for primary tumor metastatic potential in breast cancer", J Transl Med, 10, pp.226~ (2012)
- Hosono S, "Expression of Twist increases the risk for recurrence and for poor survival in epithelial ovarian carcinoma patients", Br J Cancer, 96, pp.314~320 (2007)
- Terauchi M, "Possible involvement of TWIST in enhanced peritoneal metastasis of epithelial ovarian carcinoma", Clin Exp Metastasis, 24, pp.329~339 (2007)
- Kyo S, "High Twist expression is involved in infiltrative endometrial cancer and affects patient survival", Hum Pathol, 37, pp.431~438 (2006)
- Wallerand H, "The epithelial-mesenchymal transition-inducing factor TWIST is an attractive target in advanced and", or metastatic bladder and prostate cancers, 2010, pp.28, 473~479
- 신동훈, "Relationship between the Endogenous Hypoxic Markers Hypoxia Inducible Factor-1α, Carbonic Anhydrase IX, and Epithelial Mesenchymal Transition Regulator TWIST Expression in Non-small Cell Lung Cancer", Journal of Pathology and Translational Medicine, 44(5), pp.469~476 (2010), 대한병리학회
- Gao XH, "Overexpression of twist and matrix metalloproteinase-9 with metastasis and prognosis in gastric cancer", Asian Pac J Cancer Prev, 14, pp.5055~5060 (2013)
- Arumugam T, "Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer", Cancer Res, 69, pp.5820~5828 (2009)
- Buehler D, "Expression of epithelial-mesenchymal transition regulators SNAI2 and TWIST1 in thyroid carcinomas", Mod Pathol, 26, pp.54~61 (2013)
- Jouppila-Mättö A, "Twist and snai1 expression in pharyngeal squamous cell carcinoma stroma is related to cancer progression", BMC Cancer, 11, pp.350~ (2011)
- Zhang Z, "Significance of TWIST expression and its association with E-cadherin in bladder cancer", Hum Pathol, 38, pp.598~606 (2007)
- Wang X, "Identification of a novel function of TWIST, a bHLH protein, in the development of acquired taxol resistance in human cancer cells", Oncogene, 23, pp.474~482 (2004)
- Ruan K, "Role of hypoxia in the hallmarks of human cancer", J Cell Biochem, 107, pp.1053~1062 (2009)
- Yang MH, "Direct regulation of TWIST by HIF-1alpha promotes metastasis", Nat Cell Biol, 10, pp.295~305 (2008)
- Feng Z, "Aberrant expression of hypoxia-inducible factor 1alpha, TWIST and E-cadherin is associated with aggressive tumor phenotypes in endometrioid endometrial carcinoma", Jpn J Clin Oncol, 43, pp.396~403 (2013)
- O’Neill CJ, "An immunohistochemical comparison between low-grade and high-grade ovarian serous carcinomas: significantly higher expression of p53, MIB1, BCL2, HER-2", neu, and C-KIT in high-grade neoplasms, 2005, pp.29, 1034~1041
- Stasinopoulos IA, "HOXA5-twist interaction alters p53 homeostasis in breast cancer cells", J Biol Chem, 280, pp.2294~2299 (2005)
- Maestro R, "Twist is a potential oncogene that inhibits apoptosis", Genes Dev, 13, pp.2207~2217 (1999)
- Havrilesky L, "Prognostic significance of p53 mutation and p53 overexpression in advanced epithelial ovarian cancer: a Gynecologic Oncology Group Study", J Clin Oncol, 21, pp.3814~3825 (2003)
- Kajiyama H, "Twist expression predicts poor clinical outcome of patients with clear cell carcinoma of the ovary", Oncology, 71, pp.394~401 (2006)
- Yoshida J, "Changes in the expression of E-cadherin repressors, Snail, Slug, SIP1, and Twist, in the development and progression of ovarian carcinoma: the important role of Snail in ovarian tumorigenesis and progression", Med Mol Morphol, 42, pp.82~91 (2009)